Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Moat Score: 0/10 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600381 Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
64 GF Score
Price ¥4.20
GF Value ¥5.85
Valuation Modestly Undervalued
View Full Analysis

What is Qinghai Spring Medicinal Resources Technology Co Moat Score?

Qinghai Spring Medicinal Resources Technology Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Qinghai Spring Medicinal Resources Technology Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Qinghai Spring Medicinal Resources Technology Co might have No Moat - No discernible moat.

Qinghai Spring Medicinal Resources Technology Co  (SHSE:600381) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Qinghai Spring Medicinal Resources Technology Co Moat Score Related Terms

SHSE:600381
64GF Score
Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Overvalued in 2026?

Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co stock appears to be undervalued. The current stock price of ¥4.20 is trading 28.2% below its estimated GF Value™ of ¥5.85. GuruFocus considers Qinghai Spring Medicinal Resources Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:600381:

  • Moat Score: 0
  • GF Value™: ¥5.85 vs. price of ¥4.20 (28.2% below fair value)
  • GF Score™: 64/100

No single metric tells the full story. See the SHSE:600381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qinghai Spring Medicinal Resources Technology Co Business Description

Address East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
64GF Score

Get the complete analysis for SHSE:600381

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.20
Price
¥5.85
GF Value